| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/04/1989 | US4818682 In vitro detection of gastrointestinal cancer |
| 04/04/1989 | US4818678 Mammalian monoclonal receptor reacts with viral antigens |
| 04/04/1989 | CA1252046A1 Methods for oncogenic detection |
| 03/29/1989 | EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells |
| 03/29/1989 | EP0308757A1 Multidentate chelators based on the 8-hydroxyquinoline unit |
| 03/29/1989 | EP0308724A2 Use of a immunistimulating biologic to manufacture a medicament to treat human immunodeficiency virus |
| 03/29/1989 | EP0308475A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae |
| 03/28/1989 | US4816567 Immunology, vectors, dna |
| 03/28/1989 | US4816561 Biologically active polypeptides |
| 03/28/1989 | US4816449 Immunotherapeutic anti-inflammatory peptide agents |
| 03/28/1989 | US4816417 Assay for 1,25-dihydroxy vitamin D in sample containing vitamin D transport protein |
| 03/28/1989 | US4816409 Water insoluble antitumor monoclonal antibodies |
| 03/28/1989 | US4816404 Monoclonal antibodies producing hybridomas |
| 03/28/1989 | US4816400 Basement membrane collagen degrading enzyme and method of purifying same |
| 03/28/1989 | US4816397 Genetic engineering |
| 03/28/1989 | US4816390 Monoclonal or polyclonal antibodies |
| 03/28/1989 | US4816252 Feeds for cattle |
| 03/28/1989 | US4816249 Monoclonal anti-idiotype antibodies |
| 03/28/1989 | CA1251747A1 Monoclonal antibody to candida albicans cytoplasmic antigens and methods of preparing same |
| 03/28/1989 | CA1251729A1 In vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
| 03/23/1989 | WO1989002600A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002599A1 Detection of survived, undegraded carbohydrate epitopes as diagnostic of intestinal diseases |
| 03/23/1989 | WO1989002465A2 Polypeptide production |
| 03/23/1989 | WO1989002443A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002442A1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
| 03/23/1989 | WO1989002268A1 Pharmaceutical presentation potentializing the cytotrophic effect of animal and/or human sera and/or antitissue antibodies |
| 03/23/1989 | WO1989001973A3 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/23/1989 | EP0222003A4 MOLECULAR CLONING OF cDNA FOR HUMAN FACTOR VIIIR (VON WILLEBRAND FACTOR). |
| 03/22/1989 | EP0308378A2 Tumor necrosis factor (TNF)inhibitory protein and its purification |
| 03/22/1989 | EP0308265A2 Methods and compositions relating to regression-associated antigens |
| 03/22/1989 | EP0308239A2 Method for reducing bacterial endotoxin contamination in solutions of macromolecules |
| 03/22/1989 | EP0308235A2 Attachment of compounds to polymeric particles using carbamoylonium compounds |
| 03/22/1989 | EP0308208A1 Modified antibody conjugates with enhanced clearance |
| 03/22/1989 | EP0308067A2 Alpha-amidating enzyme compositions and processes for their production and use |
| 03/22/1989 | EP0307939A1 Advanced glycosylation endproducts and associated methods |
| 03/22/1989 | EP0307754A2 Method for obtaining a papain-free antibody fragment preparation |
| 03/22/1989 | EP0307513A2 Pulmonary hydrophobic surfactant-associated proteins |
| 03/22/1989 | EP0307480A1 Process for preparing antibody complex |
| 03/22/1989 | EP0307476A1 Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use |
| 03/21/1989 | US4814434 Inducer of T-suppressor cells |
| 03/21/1989 | US4814433 Method for obtaining a papain-free antibody fragment preparation |
| 03/21/1989 | US4814277 Method of inactivating reproductive filterable pathogens |
| 03/21/1989 | US4814275 Monoclonal hybridoma antibody specific for a human epithelial antigen |
| 03/21/1989 | US4814169 Innoculating animals, spleen cells, immunology |
| 03/15/1989 | EP0307186A2 Anti-ganglioside GD1a monoclonal antibody MZ, MZ-producing cells and MZ-containing reagent |
| 03/15/1989 | EP0306995A2 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/15/1989 | EP0306943A2 Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 03/15/1989 | EP0306680A2 Monoclonal antibodies to anti-thrombin binding substance, and their uses |
| 03/09/1989 | WO1989002078A1 Method for diagnosing chronic articular rheumatism |
| 03/09/1989 | WO1989002077A1 Preparation containing high molecular staphylococcal protein; antibody preparation directed against the protein; and the use of the preparations |
| 03/09/1989 | WO1989001975A1 Recombinant antibodies and methods for their production |
| 03/09/1989 | WO1989001974A1 Recombinant antibody |
| 03/09/1989 | WO1989001973A2 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/09/1989 | WO1989001947A1 Protein derived from living body |
| 03/09/1989 | WO1989001943A1 Peptide complexes having enhanced stability |
| 03/09/1989 | WO1989001940A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 03/09/1989 | WO1989001785A1 Monoclonal antibodies to a plasmodium falciparum protein |
| 03/09/1989 | WO1989001784A1 Production of immunoproximity catalysts |
| 03/09/1989 | WO1989001783A2 Recombinant antibody and method |
| 03/09/1989 | WO1989001782A1 Recombinant antibody |
| 03/09/1989 | WO1989001773A1 Synovial phospholipases |
| 03/08/1989 | EP0306360A1 Method for the preparation of antigenic fractions used in the detection of antibodies indicative of cardiovascular trouble, antigenic fractions thus obtained and their use in the diagnosis of a cardiovascular risk |
| 03/08/1989 | EP0306303A1 Anti-viral neoantigen antibodies and anti-idiotypic antibodies induced thereby as anti-viral agents |
| 03/08/1989 | EP0306219A2 Novel HIV proteins and peptides useful in the diagnosis, prophylaxis or therapy of AIDS |
| 03/08/1989 | EP0305967A2 Conjugates of interferon alpha with immunoglobulins |
| 03/08/1989 | EP0305960A2 A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use |
| 03/08/1989 | EP0305870A2 Production of immunoproximity catalysts |
| 03/08/1989 | EP0305619A1 Monoclonal antibody, process for preparation thereof and diagnostic drug containing the same |
| 03/08/1989 | EP0305468A1 B-cell growth and differentiating factor BCGF 12K for use in therapy |
| 03/07/1989 | US4810781 Immunology, monoclonal antibodies, complexing, fragmentation |
| 03/07/1989 | US4810643 Production of pluripotent granulocyte colony-stimulating factor |
| 03/07/1989 | US4810491 Polypeptides useful in vaccination against enteroviruses |
| 03/01/1989 | EP0305320A2 Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them |
| 03/01/1989 | EP0305229A1 Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus |
| 03/01/1989 | EP0304628A2 Immunoassay for CK-MM isoenzymes |
| 03/01/1989 | EP0304481A1 Monoclonal antibodies produced against glomerular proteoglycans |
| 02/28/1989 | US4808704 Monoclonal antibodies to cell surface antigens of human malignant melanoma |
| 02/28/1989 | US4808700 Vaccine for immunization of young mammals against infections |
| 02/28/1989 | US4808536 Human t-cell lymphotropic virus; acquired immunodeficiency syndrome; in kit form; screening |
| 02/28/1989 | US4808528 Specificity for type iv collagenase enzyme antigens |
| 02/28/1989 | US4808314 Method for reducing bacterial endotoxin contamination in solutions of macromolecules |
| 02/28/1989 | CA1250587A1 Method and agents for measuring protein aging |
| 02/23/1989 | WO1989001631A1 Assay for 1,25-dihydroxy vitamin d |
| 02/23/1989 | WO1989001630A1 Procedure for relieving cell mixtures and tissues of unwanted populations |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001628A1 Monoclonal antibodies reactive with cytomegalovirus glycoprotein a |
| 02/23/1989 | WO1989001494A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 02/23/1989 | WO1989001490A2 Biologically active molecules |
| 02/23/1989 | WO1989001343A1 Cationized antibodies for delivery through the blood-brain barrier |
| 02/23/1989 | WO1989001340A1 Method for treating malignancy and autoimmune disorders in humans |
| 02/23/1989 | WO1989001339A1 Hyper-immune globulin against hiv |
| 02/23/1989 | WO1989001337A1 Methods and compositions for mimicking antigenic determinants |
| 02/23/1989 | WO1989001335A1 Biospecific polymers |
| 02/22/1989 | EP0304329A2 Monoclonal antibodies and hybridomas and sensitized cells for HBs antigen assay |
| 02/22/1989 | EP0304292A2 Antibody to propeptide of procollagen type III, and assay method using it |
| 02/22/1989 | EP0304291A1 Dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease |
| 02/22/1989 | EP0304161A2 Separation of immunoglobulin G subclasses |
| 02/22/1989 | EP0304013A2 A novel senile amyloid precursor protein and an antibody specific for the same |
| 02/22/1989 | EP0303983A2 Synthetic peptides, antibodies directed against them and their use |
| 02/22/1989 | EP0303692A1 Cloning of lfa-1 |